Munar Pharma

Munar Pharma EBIT/Assets

Delisted

The Operating Income to Assets Ratio (EBIT/Assets) of Munar Pharma (MUN.WA) as of Nov 20, 2026 is -148.69 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -177.55 % — a change of -16.25% (higher).

EBIT/Assets

-148.69 %

YoY

-16.25%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Munar Pharma is 2024 -148.69 % . Operating Income to Assets Ratio (EBIT/Assets) of Munar Pharma was 2023 -177.55 % . It decreases by -16.25% higher compared to the previous year.

The Munar Pharma EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2017
-1.26 PLN
Jan 1, 2018
-312.13 PLN
Jan 1, 2019
-2.40 PLN
Jan 1, 2020
-49.63 PLN
Jan 1, 2021
-22.68 PLN
Jan 1, 2022
4.13 PLN
Jan 1, 2023
-177.55 PLN
Jan 1, 2024
-148.69 PLN
The Munar Pharma EBIT/Assets history
YEAREBIT/AssetsYoY
-148.69 %-16.25%
-177.55 %-4,403.29%
4.13 %-118.19%
-22.68 %-54.30%
-49.63 %+1,967.15%
-2.40 %-99.23%
-312.13 %+24,657.16%
-1.26 %-171.51%
1.76 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Munar Pharma stock

Operating Income to Assets Ratio (EBIT/Assets) of Munar Pharma is -148.69 % in 2024.

Operating Income to Assets Ratio (EBIT/Assets) of Munar Pharma changed from -177.55 % to -148.69 %, representing a -16.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Munar Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Munar Pharma

All Key Metrics — Munar Pharma